P203 FIT and FC as a surrogate non-invasive marker for mucosal healing in inflammatory bowel disease
ECCO'20 Vienna
2020
P204 Re-established CRP cut-off in UC; it may be a better predictor of mucosal remission
ECCO'20 Vienna
2020
P205 Assessing the impact of age at diagnosis on transition process in patients with inflammatory bowel diseases from paediatric to adult care
ECCO'20 Vienna
2020
P206 Demographic data and therapy before proctocolectomy with ileal pouch-anal anastomosis are associated with long-term pouch outcomes: A report from the epi-IIRN
ECCO'20 Vienna
2020
P207 Modelling 1-year surgery risk in Crohn’s disease: A retrospective cohort study
ECCO'20 Vienna
2020
P208 Correlation between physician and patient disease assessments in ulcerative colitis: 2-year UK data from the ICONIC study
ECCO'20 Vienna
2020
P209 Prospective validation of faecal calprotectin as a predictor of steroid failure in patients with acute severe colitis
ECCO'20 Vienna
2020
P210 Clostridium difficile infection in pre-existing inflammatory bowel disease: Management and outcomes
ECCO'20 Vienna
2020
P211 Positivity of stool sampling for enteric pathogens during inflammatory bowel disease flares in paediatric patients and its impact on disease outcomes
ECCO'20 Vienna
2020
P212 Deep learning video analysis for a fully automated per-frame grading of ulcerative colitis
ECCO'20 Vienna
2020
P213 Can artificial intelligence help differentiate inflammatory intestinal diseases in China? Models applying random forest and convolutional neuron network
ECCO'20 Vienna
2020
P215 The effect of resection margin involvement of Crohn’s disease on the surgical and clinical recurrence after intestinal surgery
ECCO'20 Vienna
2020
P216 Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
ECCO'20 Vienna
2020
P217 The role of 7-alfa-hydroxy-4-cholesten-3-one (C4) as a biomarker for bile acid malabsorption in inflammatory bowel disease and microscopic colitis
ECCO'20 Vienna
2020
P218 Linked colour imaging predicts the risk of the clinical relapse in ulcerative colitis
ECCO'20 Vienna
2020
P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
ECCO'20 Vienna
2020
P220 Predictors of prognosis after discontinuation of first-use biologics in IBD patients with at least 24 months follow-up
ECCO'20 Vienna
2020